FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560708839> ?p ?o ?g. }

• W2560708839 endingPage "150" @default.
• W2560708839 startingPage "143" @default.
• W2560708839 abstract "Objectives: We tested the hypothesis that a C -reactive protein and ferritin-based systemic inflammation contingency table can track mortality risk in pediatric severe sepsis. Design: Prospective cohort study. Setting: Tertiary PICU. Patients: Children with 100 separate admission episodes of severe sepsis were enrolled. Interventions: Blood samples were attained on day 2 of sepsis and bi-weekly for biomarker batch analysis. A 2 × 2 contingency table using C -reactive protein and ferritin thresholds was developed. Measurements and Main Results: A C -reactive protein of 4.08 mg/dL and a ferritin of 1,980 ng/mL were found to be optimal cutoffs for outcome prediction at first sampling ( n = 100) using the Youden index. PICU mortality was increased in the “high-risk” C -reactive protein greater than or equal to 4.08 mg/dL and ferritin greater than or equal to 1,980 ng/mL category (6/13 [46.15%]) compared with the “intermediate-risk” C -reactive protein greater than or equal to 4.08 mg/dL and ferritin less than 1,980 ng/mL or C -reactive protein less than 4.08 mg/dL and ferritin greater than or equal to 1,980 ng/mL categories (2/43 [4.65%]), and the “low-risk” C -reactive protein less than 4.08 mg/dL and ferritin less than 1,980 ng/mL category (0/44 [0%]) (odds ratio, 36.43 [95% CI, 6.16–215.21]). The high-risk category was also associated with the development of immunoparalysis (odds ratio, 4.47 [95% CI, 1.34–14.96]) and macrophage activation syndrome (odds ratio, 24.20 [95% CI, 5.50–106.54]). Sixty-three children underwent sequential blood sampling; those who were initially in the low-risk category ( n = 24) and those who subsequently migrated ( n = 19) to the low-risk category all survived, whereas those who remained in the “at-risk” categories had increased mortality (7/20 [35%]; p < 0.05). Conclusions: A C -reactive protein- and ferritin-based contingency table effectively assessed mortality risk. Reduction in systemic inflammation below a combined threshold C -reactive protein of 4.08 mg/dL and ferritin of 1,980 ng/mL appeared to be a desired response in children with severe sepsis." @default.
• W2560708839 created "2016-12-16" @default.
• W2560708839 creator A5007779144 @default.
• W2560708839 creator A5012028041 @default.
• W2560708839 creator A5037074204 @default.
• W2560708839 creator A5060662565 @default.
• W2560708839 creator A5062295043 @default.
• W2560708839 creator A5073116106 @default.
• W2560708839 creator A5074292057 @default.
• W2560708839 creator A5090566720 @default.
• W2560708839 date "2017-02-01" @default.
• W2560708839 modified "2023-10-02" @default.
• W2560708839 title "A Systemic Inflammation Mortality Risk Assessment Contingency Table for Severe Sepsis*" @default.
• W2560708839 cites W1488866398 @default.
• W2560708839 cites W1505537322 @default.
• W2560708839 cites W1570331116 @default.
• W2560708839 cites W1913742176 @default.
• W2560708839 cites W1967173230 @default.
• W2560708839 cites W1972458687 @default.
• W2560708839 cites W1981940713 @default.
• W2560708839 cites W1983691837 @default.
• W2560708839 cites W1984666117 @default.
• W2560708839 cites W2016541749 @default.
• W2560708839 cites W2026170842 @default.
• W2560708839 cites W2037917480 @default.
• W2560708839 cites W2049041473 @default.
• W2560708839 cites W2056411965 @default.
• W2560708839 cites W2059766682 @default.
• W2560708839 cites W2070743921 @default.
• W2560708839 cites W2076590961 @default.
• W2560708839 cites W2085128602 @default.
• W2560708839 cites W2085382520 @default.
• W2560708839 cites W2085439684 @default.
• W2560708839 cites W2090668142 @default.
• W2560708839 cites W2119893731 @default.
• W2560708839 cites W2122550341 @default.
• W2560708839 cites W2127653619 @default.
• W2560708839 cites W2138904389 @default.
• W2560708839 cites W2155063280 @default.
• W2560708839 cites W2156828749 @default.
• W2560708839 cites W2158385322 @default.
• W2560708839 cites W2159101699 @default.
• W2560708839 cites W2177407033 @default.
• W2560708839 cites W2328429867 @default.
• W2560708839 doi "https://doi.org/10.1097/pcc.0000000000001029" @default.
• W2560708839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5291785" @default.
• W2560708839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27941423" @default.
• W2560708839 hasPublicationYear "2017" @default.
• W2560708839 type Work @default.
• W2560708839 sameAs 2560708839 @default.
• W2560708839 citedByCount "58" @default.
• W2560708839 countsByYear W25607088392017 @default.
• W2560708839 countsByYear W25607088392018 @default.
• W2560708839 countsByYear W25607088392019 @default.
• W2560708839 countsByYear W25607088392020 @default.
• W2560708839 countsByYear W25607088392021 @default.
• W2560708839 countsByYear W25607088392022 @default.
• W2560708839 countsByYear W25607088392023 @default.
• W2560708839 crossrefType "journal-article" @default.
• W2560708839 hasAuthorship W2560708839A5007779144 @default.
• W2560708839 hasAuthorship W2560708839A5012028041 @default.
• W2560708839 hasAuthorship W2560708839A5037074204 @default.
• W2560708839 hasAuthorship W2560708839A5060662565 @default.
• W2560708839 hasAuthorship W2560708839A5062295043 @default.
• W2560708839 hasAuthorship W2560708839A5073116106 @default.
• W2560708839 hasAuthorship W2560708839A5074292057 @default.
• W2560708839 hasAuthorship W2560708839A5090566720 @default.
• W2560708839 hasBestOaLocation W25607088392 @default.
• W2560708839 hasConcept C105795698 @default.
• W2560708839 hasConcept C126322002 @default.
• W2560708839 hasConcept C156957248 @default.
• W2560708839 hasConcept C185592680 @default.
• W2560708839 hasConcept C188816634 @default.
• W2560708839 hasConcept C2776252253 @default.
• W2560708839 hasConcept C2776914184 @default.
• W2560708839 hasConcept C2778319317 @default.
• W2560708839 hasConcept C2778384902 @default.
• W2560708839 hasConcept C2781195455 @default.
• W2560708839 hasConcept C2781197716 @default.
• W2560708839 hasConcept C33923547 @default.
• W2560708839 hasConcept C44249647 @default.
• W2560708839 hasConcept C55493867 @default.
• W2560708839 hasConcept C71924100 @default.
• W2560708839 hasConcept C90924648 @default.
• W2560708839 hasConcept C91998498 @default.
• W2560708839 hasConceptScore W2560708839C105795698 @default.
• W2560708839 hasConceptScore W2560708839C126322002 @default.
• W2560708839 hasConceptScore W2560708839C156957248 @default.
• W2560708839 hasConceptScore W2560708839C185592680 @default.
• W2560708839 hasConceptScore W2560708839C188816634 @default.
• W2560708839 hasConceptScore W2560708839C2776252253 @default.
• W2560708839 hasConceptScore W2560708839C2776914184 @default.
• W2560708839 hasConceptScore W2560708839C2778319317 @default.
• W2560708839 hasConceptScore W2560708839C2778384902 @default.
• W2560708839 hasConceptScore W2560708839C2781195455 @default.
• W2560708839 hasConceptScore W2560708839C2781197716 @default.
• W2560708839 hasConceptScore W2560708839C33923547 @default.
• W2560708839 hasConceptScore W2560708839C44249647 @default.

• next